Articles

Use of immunosuppressive therapy for management of myelodysplastic syndromes: a systematic review and meta-analysis

Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
Department of Internal Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT
Department of Internal Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT
Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT;Department of Chronic Disease Epidemiology, School of Public Health, Yale University, New Haven, CT, USA
Department of Internal Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT;Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT
Vol. 105 No. 1 (2020): January, 2020 https://doi.org/10.3324/haematol.2019.219345